{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:34:47Z","timestamp":1770507287751,"version":"3.49.0"},"reference-count":25,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1136\/jnnp-2013-306014","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T04:48:40Z","timestamp":1385095720000},"page":"618-624","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP"],"prefix":"10.1136","volume":"85","author":[{"given":"R.","family":"Press","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Askmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. W.","family":"Axelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Stromberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-E. J.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hagglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"key-10.1136\/jnnp-2013-306014-1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nature Review Neurol"},{"key":"key-10.1136\/jnnp-2013-306014-2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014First Revision","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2013-306014-3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/ern.09.30","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial","volume":"9","author":"Hughes","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"key-10.1136\/jnnp-2013-306014-4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1468-1331.2009.02802.x","article-title":"A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"17","author":"Cocito","year":"2010","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2013-306014-5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-306014-6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1529-8027.2010.00284.x","article-title":"Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice","volume":"15","author":"Gorson","year":"2010","journal-title":"JPNS"},{"key":"key-10.1136\/jnnp-2013-306014-7","first-page":"66","article-title":"Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases","volume":"77","author":"Kuwabara","year":"2006","journal-title":"JNNP"},{"key":"key-10.1136\/jnnp-2013-306014-8","first-page":"677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England","volume":"66","author":"Lunn","year":"1999","journal-title":"JNNP"},{"key":"key-10.1136\/jnnp-2013-306014-9","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/14712598.2011.580272","article-title":"Autologous haemopoietic stem cell transplantation for autoimmune diseases","volume":"11","author":"Zeher","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"key-10.1136\/jnnp-2013-306014-10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13311-011-0062-0","article-title":"Immune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis","volume":"8","author":"Gosselin","year":"2011","journal-title":"Neurotherapeutics"},{"key":"key-10.1136\/jnnp-2013-306014-11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.cco.0000152974.65477.35","article-title":"High-dose therapy for autoimmune neurologic diseases","volume":"17","author":"Drachman","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"key-10.1136\/jnnp-2013-306014-12","first-page":"127","article-title":"Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"72","author":"Vermeulen","year":"2002","journal-title":"JNNP"},{"key":"key-10.1136\/jnnp-2013-306014-13","first-page":"1154","article-title":"Relapse of chronic inflammatory demyelinating polyneuropathy 5\u2005years after autologous stem cell transplantation","volume":"78","author":"Vermeulen","year":"2007","journal-title":"JNNP"},{"key":"key-10.1136\/jnnp-2013-306014-14","first-page":"S132","article-title":"Autologous peripheral blood progenitor cell transplantation in refractory chronic inflammatory demyelinating polyradiculopathy","volume":"37","author":"Kamat","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"key-10.1136\/jnnp-2013-306014-15","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.wnl.0000277266.53449.8b","article-title":"Nonmyeloablative autologous hematopoietic stem cell transplantation for refractory CIDP","volume":"18","author":"Oyama","year":"2007","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-306014-16","first-page":"612","article-title":"Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP","volume":"79","author":"Axelson","year":"2008","journal-title":"JNNP"},{"key":"key-10.1136\/jnnp-2013-306014-17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","article-title":"Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy","volume":"14","author":"Mahdi-Rogers","year":"2009","journal-title":"JPNS"},{"issue":"(Suppl 1)","key":"key-10.1136\/jnnp-2013-306014-18","first-page":"P7","article-title":"Autologous stem cell transplantation in a patient with a chronic demyelinating neuropathy and persistent conduction block [abstract]","volume":"12","author":"Barreira","year":"2007","journal-title":"JPNS"},{"key":"key-10.1136\/jnnp-2013-306014-19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"13","author":"Hughes","year":"2006","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2013-306014-20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"2","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2013-306014-21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"3","author":"Banks","year":"2007","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2013-306014-22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mus.21733","article-title":"Electrophysiologic correlations with clinical outcomes in CIDP","volume":"42","author":"Bril","year":"2010","journal-title":"Muscle Nerve"},{"key":"key-10.1136\/jnnp-2013-306014-23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneurol.2010.143","article-title":"Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"67","author":"Wolf","year":"2010","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2013-306014-24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.bbmt.2012.06.008","article-title":"Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation","volume":"18","author":"Kim","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"key-10.1136\/jnnp-2013-306014-25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1083-8791(03)00228-3","article-title":"Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases","volume":"9","author":"Nash","year":"2003","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2013-306014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:53:00Z","timestamp":1601056380000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2013-306014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,5,6]]},"published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp-2013-306014","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}